Source-labeled summaries of peptide research, mechanisms, study designs, and literature context.
Source-labeled summaries of peptide research, mechanisms, study designs, and literature context.
A source-labeled breakdown of the Retatrutide Phase 2 trial population, randomized arms, endpoints, timepoints, and study-design limitations.
A focused literature review of mechanisms and metabolic research involving MOTS-C.
A source-labeled review of human and exercise-related MOTS-C research, separated from preclinical evidence.
A focused review of BDNF and gene-expression findings discussed in published Semax research.
A source-labeled separation of human Semax studies from animal, cell, and mechanistic research.
A focused literature review of Tesamorelin mechanism and IGF-1 findings reported in cited studies.
A source-labeled review of study durations, endpoints, and outcome measurements reported in Tesamorelin trials.
A focused review of mechanisms discussed in GHK-Cu research, with clear separation between mechanistic and outcome evidence.
A source-labeled review separating human GHK-Cu research from cell and animal evidence, with study designs and limitations.
A research-context guide to when Retatrutide trial outcomes were measured, separating study timepoints from anecdotal expectations.
A source-labeled review of body-composition and lean-mass measurements reported in Retatrutide research and the limits of available evidence.
A research-design comparison of Retatrutide and tirzepatide, including direct head-to-head trial information when available and limits of cross-study comparisons.